Press Release: Antidote Technologies to present at the 14th annual Tech Tour Growth Health Program

Antidote will join 20 select digital health companies for exclusive networking with prominent investors and corporations at the Lausanne event taking place on June 20th and 21st.

London, UK (June 19, 2023) — Antidote Technologies (“Antidote”), a digital patient engagement company operating in the clinical trial recruitment sector, has been selected to participate in Tech Tour Growth Health Programme 2023. Tech Tour, an organization renowned for its community platform that connects entrepreneurs from digital health, MedTech, and biotech with investors, experts, coaches, and corporations, has hosted this annual health tech event in Europe since 2009. 

The event is set to attract over 100 investors, corporations, innovators, and esteemed guests who possess deep expertise in the field. This diverse and influential audience creates an exceptional environment for networking, collaboration, and knowledge exchange. By presenting at this eminent event, Antidote will gain invaluable exposure and opportunities to engage with key stakeholders, paving the way for potential partnerships, investments, and further growth.

The focus of Antidote’s presentation will include an overview of the company, its journey since its founding in 2010, its mission, and its growth as a prominent player in the clinical trial recruitment sector. They will also present a forward-looking view on future investments, specifically Antidote’s data insights product which aims to help optimize various aspects of clinical research, including patient recruitment, trial design, site selection, and more.

“We are honoured to present at Tech Tour’s Growth Health Programme” said Laurent Schockmel, Antidote’s CEO. “I’m excited to share the work that we are doing, not just from a technical perspective, but to speak to how investing in this data insights product will make a difference in patients’ lives. By leveraging patient insights and adopting innovative approaches, we aim to help accelerate clinical trials, ultimately bringing life-saving treatments to patients and those who love them faster.”

About Antidote
Antidote is a digital health company with a mission to enable faster medical innovation by transforming how sponsors and patients connect. This is achieved via data-driven product and service offerings that are delivered with a patient-centric, human touch. Through precision recruitment and an extensive partner network, Antidote is able to match the right patients with the right research opportunities, advancing medical breakthroughs and increasing clinical trial participation. Antidote was launched as TrialReach and is based in the US and UK. For more information, please visit

About Tech Tour
Tech Tour is Europe’s largest tech investment community. It supports entrepreneurs to raise investments and to grow, progressing their innovative solutions and addressing global challenges. In its 25th anniversary year, Tech Tour brings together 1,000+ selected tech companies with Europe’s 1,000+ most active investors and corporate partners across 25 invitation-only Programmes covering all of Europe and all tech sectors including digital, health and sustainability.  For more information, please visit

Media Contact
Amanda McDowell
Content Marketing Manager, Antidote